Batch 001 - Live Allocation

Next Release: Aug 2026

Vivre Labs

Institutional Longevity

Catalogue
Single-vial Blends · one injection
Clinical Details

- Peptides -

- Single-vial Blends -

- Goals -

- Clinical Reference -

- Guides -

- Integrity -

◇ Compound Reference

REPRODUCTIVE PEPTIDEInvestigational

Kisspeptin-10

GnRH Stimulator · 10mg

Status

Investigational

Route

SubQ

Half-life

~30 minutes plasma

Class

Reproductive neuropeptide

MechanismGPR54 Receptor Agonism

Cohort19 active prescriptions

Educational reference only - not a prescription or dosing recommendation. Some compounds are investigational or used off-label; suitability, dose, and monitoring are determined by your supervising physician. See Informed Consent & Disclaimer.

V-Series Member

$80 USD/vial

À-la-carte: $90 USD/vial · Save 11%

Vials per allocation

Member total (1×)$80

À-la-carte total$90

Flat per-vial pricing. Quantity is allocated and dispensed within your physician-supervised protocol - not a direct sale.

What this is

Hypothalamic GnRH pulse regulator. Applications in reproductive endocrinology and HPG axis restoration protocols.

GnRH Stimulator · 10mg per vial · dispensed after a physician review.

◇

Janoshik Verified

HPLC + MS purity, every batch

Independent third-party lab

⬡

COA Per Batch

Lot-level certificates published

Labeled vs actual mg disclosed

⊙

Protocol Reviewed

Used in V-Series clinical stacks

Phase 1 supervision onboarding

Kisspeptin-10 · Reproductive Peptide

◆ Certificate of Analysis · Kisspeptin-10

JANOSHIK ANALYTICALHPLC + MS · Independent third-party

Lot-specific COAs for Kisspeptin-10 are published with each batch release. Sample certificates available on request via partnerships@vivrelabs.com.

◉

Clinical Overview

Kisspeptin-10

Kisspeptin-10 is a 10-amino-acid fragment of the parent kisspeptin peptide. Acts as a master regulator of the hypothalamic-pituitary-gonadal axis through GnRH neuron stimulation.

✦

Reproductive Axis

Activates KISS1R on GnRH neurons; upstream reproductive regulator.

❖

Pulsatile GnRH

Drives physiological pulsatile GnRH release.

◈

Investigational

Largely investigational for endocrine applications.

◈

Mechanism

How It Works

Activates GPR54 (KISS1R) receptors on GnRH neurons in the hypothalamus, driving pulsatile GnRH release. The natural upstream regulator of reproductive endocrinology.

Mechanism & evidence - the honest frame

Evidence frame: kisspeptin is the natural upstream trigger of the reproductive axis - it activates KISS1R on hypothalamic GnRH neurons, driving GnRH → LH/FSH → downstream testosterone/estrogen. The physiology is well-established and it is an active area of reproductive-endocrinology research (fertility, hypothalamic amenorrhoea, HPG evaluation). Honest status: human use is largely INVESTIGATIONAL - there is no approved kisspeptin product, and most data is research/early-clinical rather than large outcome trials. The theoretical concern that sustained or supraphysiologic exposure could blunt the axis (receptor desensitisation) is mechanistically plausible but not well-characterised in humans; it is a reason for physician-determined, pulsatile/cyclical use, not a self-managed protocol. Vivre presents this as endocrine-axis physiology, not a libido performance product.

✚

Patient Bloodwork Guide

Bloodwork for Cognitive & Neuro Protocols

Nootropic / neuro - Semax, Selank, DSIP, Oxytocin, PT-141, Kisspeptin

These protocols target cognition, mood, stress regulation, and sleep. Their effects are mostly subjective and behavioral, so monitoring leans on functional and stress-axis markers more than a classic blood panel - the aim is to confirm benefit without disrupting your stress hormones or sleep architecture.

Incremental approach. These are low-dose, often short-course or as-needed protocols. Vivre tracks how you actually feel and function alongside a light marker panel, rather than chasing numbers - the subjective response is the primary signal here.

Stress axis & recovery

Cortisol rhythm (AM/PM)Confirms the protocol is calming the stress axis, not over-stimulating it. The key safety/efficacy marker for this group.

HRV (heart-rate variability)A non-blood measure of nervous-system balance and recovery - rises as stress regulation improves.

Brain & vascular health

HomocysteineElevated levels are linked to cognitive risk; a useful baseline to optimize.

BDNFA marker tied to neuroplasticity - context for neuro-supportive protocols (where testing is available).

Routine safety

CBC & CMPStandard blood count, liver, and kidney panels.

When the tests happen

BaselineCortisol rhythm, HRV, homocysteine, plus how you rate mood/focus/sleep.

Month 1HRV and a subjective check-in - is it helping, any over-stimulation?

Month 3Repeat cortisol rhythm and HRV to confirm a sustained, healthy direction.

Educational only - not medical advice or a dosing instruction. Your physician orders the tests, sets your dose, interprets results, and decides if a protocol is right for you. See the Informed Consent & Disclaimer for full terms.

⊞

Technical Profile

Measurable Properties

Class	Kisspeptin-10 (KISS1-derived peptide)
Mechanism	KISS1R agonism; upstream stimulation of GnRH / reproductive axis - characterised
Terminal half-life	Very short (minutes)
Metabolism	Rapid peptidase degradation
Evidence base	Growing human research interest; therapeutic use investigational
Regulatory status	Investigational; physician-supervised use only

Certificate of Analysis (per batch)

Analytical method: UHPLC-MS. Batch COA available on request - link to be populated per shipment.

COA link - pending per batch

Axis pharmacology characterised; therapeutic use investigational. Educational only.

Clinical Literature

Peer-Reviewed References

Kisspeptin-10 Is a Potent Stimulator of LH and Increases Pulse Frequency in Men

George JT, Veldhuis JD, Roseweir AK, et al. · 2011 · Journal of Clinical Endocrinology & Metabolism 2011;96(8):E1228–E1236

▾

Findings

Kisspeptin-10 boluses potently evoke LH secretion in men (~2.5-fold rise from baseline); continuous infusion increased testosterone, LH pulse frequency and pulse size. Notably, at the physiological dose used, no desensitisation was seen over 22.5h - in contrast to higher-dose continuous primate infusions. Establishes kisspeptin as an upstream HPG-axis regulator with therapeutic potential.

View on publisher ↗

Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

Mills EG, Ertl N, Wall MB, et al. · 2023 · JAMA Network Open 2023;6(2):e2254313

▾

Findings

Randomised, placebo-controlled crossover, 37 men with HSDD (32 completed). IV kisspeptin-54 significantly modulated brain activity in sexual-processing networks and increased penile tumescence vs placebo - without changing testosterone or cortisol in the 75-min window, supporting a central desire effect distinct from a hormonal one.

View on publisher ↗

Human kisspeptin data is real and from quality groups, but use is investigational - there is no approved kisspeptin product, the native peptide has a very short half-life (kisspeptin-10 ~minutes), and most data is acute physiological/early-clinical rather than long-term outcome trials. Vivre frames it as endocrine-axis physiology, not a libido product.

◇

Clinical Applications

Indications

HPG axis restoration following suppression
Reproductive endocrinology research
Functional hypogonadism evaluation
Specialized fertility protocols under physician oversight

⊙

Pharmacokinetics

Half-Life & Duration of Action

Half-life is how long a compound stays at active plasma concentration in your body. Most peptides in this catalogue have short plasma half-lives - they clear from your bloodstream within hours, sometimes minutes. The long-half-life compounds in this catalogue are the approved-class incretins (Tirzepatide, Semaglutide, Retatrutide), which are designed for once-weekly dosing - that's the molecular engineering choice that makes weekly dosing work.

Plasma Half-Life

~30 minutes plasma. Diagnostic protocols use bolus dosing; therapeutic protocols use pulsatile or sustained dosing.

Why this matters for you

If you don't tolerate a compound or need to discontinue a protocol, short-half-life peptides are out of your bloodstream within hours - not days or weeks. That said, the biological effects they initiate (tissue repair signalling, mitochondrial signalling, gene expression changes) often persist longer than the peptide itself, through downstream cellular cascades. This is normal peptide pharmacology and is important context - the molecule clears fast, but the biology takes longer to wind down.

Evidence Base

Active clinical research area. Use is specialized and physician-directed.

Dosing protocols, administration frequency, and titration schedules are physician-determined at consultation - not published on these public pages. Vivre maintains a separate internal clinical reference for treating physicians.

◎

Commonly Paired

Compounds Often Prescribed With Kisspeptin-10

Clinical co-allocation patterns observed in Vivre's allocation history. Pairings are not prescriptions - the physician determines suitability per patient at consultation.

Growth Hormone Secretagogue

Sermorelin

GHRH Analog · 10mg

◆ HPG + HPA axis

Kisspeptin's GnRH regulation paired with sermorelin's GHRH action - endocrine-axis restoration protocols in reproductive and growth-hormone deficient cases.

View Sermorelin detail →

READY TO PROCEED

Start with the Biological Audit

Kisspeptin-10 is verified and lot-tested, dispensed following a Biological Audit. The Audit is complimentary for the Batch 001 cohort.

$80 USD/vial

Kisspeptin-10 · Member rate